New Delhi: Bharat Biotech on Wednesday said its coronavirus vaccine Covaxin has shown efficacy of 78 per cent against mild, moderate and severe cases of COVID-19, as per Phase III interim analysis results.
...
Trending Stories
- Meghalaya: KSU members held in murder cases remanded to police
- Nagaland Police rescue kidnapped worker in daring night op; 2 held
- RBI restricts Kotak Bank; new customer onboarding halted
- Assam: AIUDF chief to challenge closure of Madrassas in SC
- Is BJP’s northeast leadership split on the resettlement of Chakma-Hajong?
- Mizoram student body warns refugees from buying property, getting ID cards
